<DOC>
	<DOCNO>NCT02043015</DOCNO>
	<brief_summary>The purpose study evaluate acceptability uptake combination package biomedical , behavioral community-level HIV prevention intervention service men sex men ( MSM ) South Africa .</brief_summary>
	<brief_title>Comprehensive HIV Prevention Package MSM Southern Africa : Pilot Study ( Sibanye Health Project )</brief_title>
	<detailed_description>Study Design : This pilot study longitudinal cohort study approximately 100 MSM , prospective follow-up period 1 year participant . MSM recruit community event , venue MSM know congregate , online , participant referral . Following consent , baseline visit include self-administered baseline survey , clinical exam include assessment circumcision STIs , test HIV STIs , creatinine , AST/ALT phosphorus level , drug screening . An HIV prevention package offer participant start baseline , include condom choice , condom-compatible lubricant choice , risk-reduction counseling , linkage care , couple voluntary counsel testing ( CVCT ) . HIV-negative men screen eligibility pre-exposure prophylaxis ( PrEP ) Emtricitabine/Tenofovir Disoproxil Fumarate ( FTC/TDF ) , make available eligible men begin 1-month 4-month study visit . Throughout study , PEP men exposure high risk HIV transmission make available . Men test positive HIV baseline study refer actively link appropriate care treatment service continue part study . Men test positive STIs baseline study receive treatment study clinic . Participants complete follow-up visit 3 , 6 , 12 month include self-administered behavioral survey HIV testing , STI test 6 12 month . Men eligible interested initiate PrEP return PrEP initiation visit , include rapid HIV testing , two time point : 1 month enrollment 4 month enrollment . Men initiate PrEP additional clinic visit creatinine , AST/ALT , phosphate , protein glucose level test rapid HIV test month follow PrEP initiation ( month 2 initiate PrEP 1 month month 5 initiate PrEP 4 month ) every 3 month thereafter . If participant PrEP test positive HIV , discontinue PrEP continue follow remain study visit . Men test positive HIV follow-up visit blood draw initial CD4 HIV viral load testing , CD4 test 6 12 month HIV viral load test 3 , 6 , 12 month . Data service utilization , condom use , lubricant use , HIV STI test outside study site , outcomes collect via monthly SMS text message survey study period . Study Population : The study population men age 18 year old self-report anal intercourse men past year , current resident study city , willing provide contact information , phone . Study Size : The sample consist approximately 100 MSM Cape Town , South Africa . All 100 men follow one year , approximately 20 % study population HIV-infected baseline . Additional men HIV-positive baseline enrol baseline visit follow prospectively , count part 100 men study site . Study Intervention : The prevention package offer throughout study include condom choice assortment style , size feature , condom-compatible lubricant choice discreet packaging , risk reduction counseling , linkage care , couple voluntary HIV counsel test ( CVCT ) , PrEP eligible men begin one month enrollment . Condom choice , lubricant choice , CVCT available participant drop-in visit time . Throughout study , post-exposure prophylaxis ( PEP ) men exposure high risk HIV transmission available standard care . Community-level intervention occur train health care provider deliver sexual health service MSM LGBT sensitization , LGBT training study staff staff clinical site , community mobilization effort improve health literacy uptake prevention service among MSM . Study Duration : Recruitment activity conduct 3 month 100 MSM recruit . After enrollment , MSM follow-up period 1 year participant . Primary Objectives : This study four primary objective : 1 . Determine acceptability HIV prevention package . 2 . Determine uptake individual element HIV prevention package . 3 . Determine incidence HIV , STIs UAI . 4 . Understand HIV risk prevention behavior among MSM . Participating Sites : 1 . Emory University , Atlanta , GA 2 . Johns Hopkins Bloomberg School Public Health , Baltimore , MD 3 . University California , Los Angeles , Los Angeles , CA 4 . Desmond Tutu HIV Foundation , Cape Town , South Africa ( Enrollment &amp; Clinic site )</detailed_description>
	<criteria>Male sex birth Anal sex another man past 12 month 18 year age old Resident study city Able complete study instrument , without assistance , English , Xhosa Afrikaans Willing provide contact information Has phone Not male sex birth No selfreported anal sex man past 12 month Less 18 year age Not resident study city Plans move study city within year enrollment Not able complete study instruction , without assistance , English , Xhosa Afrikaans Not willing provide contact information Does phone Additional Inclusion Exclusion Criteria participant PrEP : PrEP Identified highrisk HIV provider meet one criterion : Have multiple partner Engage transactional sex , include sex worker Use abuse drug Drink alcohol heavily Had 1 episode STI last year Is HIVnegative partner discordant relationship , especially HIVpositive partner antiretroviral therapy ( ART ) Is nonmonogamous concordant relationship HIVnegative partner Is unable unwilling achieve consistent use male condoms No contraindication Emtricitabine/Tenofovir Disoproxil Fumarate ( FTC/TDF ) Calculated creatinine clearance least 60 mL/min Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &lt; 2 x ULN Hepatitis B surface antigen ( HBsAg ) negative Motivated follow PrEP prescribing guideline Willing adhere daily oral dose Willing attend PrEP maintenance visit every 3 month PrEP HIV positive Signs symptom suggestive acute HIV infection Have baseline creatinine clearance &lt; 60 ml/min Are unwilling follow PrEP prescribing guideline Are unwilling attend PrEP maintenance visit every 3 month Are know hypertensive diabetes Are hepatitis B susceptible ( test HBsAg HBsAb negative ) refuse take hepatitis B vaccine series Any contraindication take FTC/TDF Proteinuria 2+ great screen Glucosuria 2+ great screening Use ARV therapy ( e.g. , PEP PrEP ) 90 day prior study entry</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>voluntary counseling testing ( VCT )</keyword>
	<keyword>couple voluntary counsel testing ( CVCT )</keyword>
	<keyword>pre-exposure prophylaxis ( PrEP )</keyword>
	<keyword>homosexuality</keyword>
	<keyword>male</keyword>
	<keyword>South Africa</keyword>
</DOC>